<?xml version="1.0" encoding="UTF-8"?>
<ref id="B70-pharmaceuticals-13-00444">
 <label>70.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kolodziejczyk-Czepas</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Sieradzka</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Moniuszko-Szajwaj</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Pecio</surname>
    <given-names>Ł.</given-names>
   </name>
   <name>
    <surname>Ponczek</surname>
    <given-names>M.B.</given-names>
   </name>
   <name>
    <surname>Nowak</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Stochmal</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>Bufadienolides from 
   <italic>Kalanchoe daigremontiana</italic> as thrombin inhibitors—In vitro and in silico study
  </article-title>
  <source>Int. J. Biol. Macromol.</source>
  <year>2017</year>
  <volume>99</volume>
  <fpage>141</fpage>
  <lpage>150</lpage>
  <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2017.02.051</pub-id>
  <pub-id pub-id-type="pmid">28223215</pub-id>
 </element-citation>
</ref>
